GGrantIndex
← Leaderboards

Andrey M Mazarati

Brentwood Biomedical Research Institute

$6,368,140
Attributed
$14,151,102
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,151,102 · 6

By mechanism

R01$12,828,230 · 3
R21$1,322,872 · 3

Top collaborators

Others in their field

Top investigators on “Epilepsy

Research focus

EpilepsyDesignIn VivoNeuronsAnimal ModelRattusSeizuresAnimalsStatus EpilepticusHippocampus (Brain)ChronicLinkSeveritiesExperimental ModelsSerotoninSwimmingMental DepressionFutureAntiepileptogenicPublic Health RelevancePlasmaPre-ClinicalEpileptogenesisPrevent

Grant awards (34)

Translational Platform for Epilepsy Therapy and Biomarker Discovery$2,036,071
R01 · FY2025 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$2,215,256
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$87,937
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$47,310
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$47,310
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$15,770
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$15,770
R01 · FY2024 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$2,122,350
R01 · FY2023 · NS
Translational Platform for Epilepsy Therapy and Biomarker Discovery$16,204
R01 · FY2023 · NS
Translational platform for epilepsy therapy and biomarker discovery$2,229,103
R01 · FY2022 · NS
Mechanisms of comorbidity between epilepsy and depression$336,481
R01 · FY2017 · NS · contact PI
Mechanisms of comorbidity between epilepsy and depression$336,481
R01 · FY2016 · NS · contact PI
Mechanisms of comorbidity between epilepsy and depression$23,723
R01 · FY2016 · NS · contact PI
Mechanisms of comorbidity between epilepsy and depression$341,230
R01 · FY2015 · NS · contact PI
Optogenetic treatment of epilepsyassociated$192,500
R21 · FY2015 · NS
Mechanisms of comorbidity between epilepsy and depression$343,545
R01 · FY2014 · NS · contact PI
Optogenetic treatment of epilepsyassociated$231,000
R21 · FY2014 · NS
Mechanisms of comorbidity between epilepsy and depression$41,087
R01 · FY2014 · NS · contact PI
Mechanisms of comorbidity between epilepsy and depression$344,695
R01 · FY2013 · NS · contact PI
Mechanisms of comorbidity between epilepsy and depression$413,407
R01 · FY2012 · NS · contact PI
Mechanisms of comorbidity between epilepsy and depression$333,080
R01 · FY2011 · NS · contact PI
Mechanisms of comorbidity between epilepsy and depression$56,980
R01 · FY2011 · NS · contact PI
Mechanisms of comorbidity between epilepsy and depression$346,024
R01 · FY2010 · NS · contact PI
Neurobiological basis of Depression as a Comorbidity in Epilepsy$195,500
R21 · FY2010 · MH · contact PI
Neurobiological basis of Depression as a Comorbidity in Epilepsy$247,500
R21 · FY2009 · MH · contact PI
Validation of High-Throughput Screening of Candidate Antiepileptogenic Drugs$168,438
R21 · FY2009 · NS · contact PI
Validation of High-Throughput Screening of Candidate Antiepileptogenic Drugs$85,809
R21 · FY2009 · NS · contact PI
Validation of High-Throughput Screening of Candidate Antiepileptogenic Drugs$202,125
R21 · FY2008 · NS · contact PI
BRAIN GALANIN RECEPTORS AND EPILEPSY$266,869
R01 · FY2006 · NS · contact PI
BRAIN GALANIN RECEPTORS AND EPILEPSY$165,793
R01 · FY2005 · NS
BRAIN GALANIN RECEPTORS AND EPILEPSY$91,657
R01 · FY2005 · NS
BRAIN GALANIN RECEPTORS AND EPILEPSY$29,697
R01 · FY2005 · NS
BRAIN GALANIN RECEPTORS AND EPILEPSY$257,450
R01 · FY2004 · NS
BRAIN GALANIN RECEPTORS AND EPILEPSY$266,950
R01 · FY2003 · NS